| Q44837689 | A comparison between time to clinical stability in community-acquired aspiration pneumonia and community-acquired pneumonia |
| Q35138146 | A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia |
| Q37882795 | A novel method for isolation of Chlamydia pneumoniae by treatment with trypsin or EDTA. |
| Q37891752 | Acute lower respiratory tract infection associated with Chlamydia pneumoniae in Germany |
| Q37885000 | Adult respiratory distress syndrome due to Chlamydia pneumoniae in a young adult. |
| Q37884184 | Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course |
| Q33594751 | Antibiotic resistance and therapeutic options in lower respiratory tract infections |
| Q37883393 | Antigenic and molecular analyses of different Chlamydia pneumoniae strains. |
| Q44919640 | Atypical pneumonia--time to breathe new life into a useful term? |
| Q37885261 | Atypical pneumonias |
| Q36272565 | Chlamydia pneumoniae |
| Q35367697 | Chlamydia pneumoniae (TWAR). |
| Q37887835 | Chlamydia pneumoniae and Chronic Pharyngitis |
| Q37881662 | Chlamydia pneumoniae antibody response in patients with acute myocardial infarction and their follow-up |
| Q37885417 | Chlamydia pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients |
| Q35892972 | Chlamydia pneumoniae pneumonia: An evolving clinical spectrum |
| Q33821294 | Chlamydia pneumoniae: defining the clinical spectrum of infection requires precise laboratory diagnosis |
| Q33558683 | Chlamydial infections |
| Q43153852 | Chlamydial respiratory infections |
| Q37868415 | Chlamydophila (Chlamydia) pneumoniae induces histidine decarboxylase production in the mouse lung. |
| Q37885334 | Clinical features of Chlamydia pneumoniae acute respiratory infection |
| Q36512610 | Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia |
| Q67525823 | Community-acquired pneumonia |
| Q72399545 | Community-acquired pneumonia in adults |
| Q33974569 | Coronary angioplasty induces rise in Chlamydia pneumoniae-specific antibodies |
| Q33572320 | Cost-effective treatment of lower respiratory tract infections |
| Q37898698 | Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases |
| Q36541516 | Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms |
| Q37074513 | Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients |
| Q35110637 | Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis |
| Q37899042 | Erythema nodosum--a manifestation of Chlamydia pneumoniae (strain TWAR) infection |
| Q37890204 | Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland |
| Q44059050 | Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of Pneumococcus. |
| Q36977911 | Experimental infection with Chlamydia pneumoniae in nonhuman primates |
| Q37148533 | Factors affecting viability and growth in HeLa 229 cells of Chlamydia sp. strain TWAR |
| Q37893037 | Factors influencing the infectivity of Chlamydia pneumoniae elementary bodies on HL cells |
| Q37899601 | Family outbreaks of psittacosis in Israel |
| Q37118408 | Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene |
| Q37889915 | Identification of Chlamydia pneumoniae-specific protein antigens in immunoblots |
| Q38037769 | Immunologic tests in the diagnosis of pulmonary infection |
| Q36181177 | Immunoscreening protocols for the identification of clinically useful antibodies and antigens |
| Q35292376 | In vitro drug susceptibility of Chlamydia sp. strain TWAR. |
| Q37897794 | In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR). |
| Q34316462 | Inflammation, infection and antimicrobial therapy in coronary heart disease--where do we currently stand? |
| Q33935550 | Interpretation of Chlamydia trachomatis antibody response in chlamydial oculogenital infection |
| Q43425149 | Isolated pleural effusion as unusual manifestation of Chlamydia pneumoniae infection |
| Q37890147 | Lack of evidence of Chlamydia pneumoniae infection in infants with acute lower respiratory tract disease |
| Q35224726 | Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with Chlamydia pneumoniae |
| Q36575019 | Pneumococcal antigen detection in bronchoalveolar lavage fluid from patients with pneumonia |
| Q40743971 | Pneumonia and chronic obstructive pulmonary disease. What special considerations does this combination require? |
| Q37900892 | Pneumonia--1987: new developments |
| Q37233458 | Prevalence of antibody to Chlamydia pneumoniae TWAR in japan. |
| Q37878526 | Prolonged respiratory failure in chlamydia pneumoniae pneumonia |
| Q37896636 | Psittacosis presenting with erythema-marginatum-like lesions--a case report and a historical review |
| Q40727853 | Quality of published reports of the prognosis of community-acquired pneumonia |
| Q48604983 | Radiographic resolution of community-acquired bacterial pneumonia in the elderly |
| Q37880695 | Rapid detection of Chlamydia pneumoniae by PCR-enzyme immunoassay. |
| Q37887640 | Rapid diagnosis of chlamydial respiratory infection in children |
| Q37893027 | Recovery ofChlamydia pneumoniae, in six patients with otitis media with effusion |
| Q37893913 | Regional differences of Chlamydia pneumoniae as causative agent of pneumonia in Sweden |
| Q35488540 | Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells |
| Q37888234 | Respiratory infection with Chlamydia pneumoniae in middle-aged and older adult outpatients |
| Q34004010 | Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection |
| Q37879495 | Seroepidemiological evidence for an association between Chlamydia pneumoniae and atherosclerosis |
| Q37899465 | Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction |
| Q35649845 | Serological investigation of pneumonia as it presents to the physician's office |
| Q37891923 | Seroprevalence of Chlamydia pneumoniae in Taiwan |
| Q35764383 | Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis |
| Q24679117 | Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines |
| Q33559443 | The incidence of Chlamydia pneumoniae lower respiratory tract infections among university students in northern California |
| Q37880009 | The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection |
| Q36473191 | The seroepidemiology of Chlamydiae in Finland over the period 1971 to 1987 |
| Q37899951 | Ultrastructural study of entry of Chlamydia strain TWAR into HeLa cells |
| Q33672291 | Use of lambda phage DNA as a hybrid internal control in a PCR-enzyme immunoassay to detect Chlamydia pneumoniae |